Riskpilot← Back to searchSign inGet full accessBD Medical Consulting AB
ABActiveOrg 5565449088Värmlandsgatan 32Research and experimental development on natural sciences and engineering · NACE 7210Est. 19970 employees
Revenue 2025
SEK 0
EBITDA margin
—
-314% vs 2024
Equity ratio
46.7%
Financial strength
Net profit 2025
SEK 117K
+800% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -1,1M | -314% |
| Net profit | SEK 117K | +800% |
| Total assets | SEK 7,7M | -6% |
| Equity | SEK 3,6M | -7% |
| Employees | 0 | — |
Legal name
BD Medical Consulting AB
Org number
5565449088
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
19 augusti 1997
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva medicinsk uppdragsforskning, medicinvetenskaplig rådgivning och konsultverksamhet, utbildning samt framtagning av utbildningsmaterial och IT-lösningar. Bolaget skall även bedriva handel och förvaltning av värdepapper och fastigheter samt med nämnda verksamheter förenlig verksamhet.
Address
Värmlandsgatan 32
Phone
+4631415298
Email
bjorn.dahlof@cerenoscientific.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 360 | 1 597 | 375 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −922 | 51 | −547 | −269 | −1 114 |
| Depreciation & amort. | −89 | −89 | −89 | −89 | −78 |
| EBIT | −1 011 | −38 | −636 | −358 | −1 192 |
| Net financials | 1 441 | 1 887 | −150 | 74 | 1 327 |
| Profit before tax | 430 | 1 379 | 114 | 38 | 164 |
| Tax | −101 | −293 | −77 | −25 | −47 |
| Net profit | 329 | 1 086 | 37 | 13 | 117 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 9 864 | 10 709 | 8 931 | 8 182 | 7 706 |
| Equity | 4 016 | 4 603 | 4 140 | 3 878 | 3 595 |
| Long-term debt | 4 331 | 4 071 | 3 811 | 3 641 | 3 481 |
| Short-term debt | 156 | 206 | 50 | 53 | 50 |
| Total debt | 4 487 | 4 277 | 3 861 | 3 694 | 3 531 |
EBITDA margin
-111400000.0%
This company
15.8%
Market median
-705063391% vs market
20212025
Equity ratio
46.7%
This company
38.2%
Market median
+22% vs market
20212025
Return on equity
3.3%
This company
18.4%
Market median
-82% vs market
20212025
Net profit margin
11700000.0%
This company
8.1%
Market median
+144444344% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
1.14×
This company
0.62×
Market median
-84% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
TH | Audit | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BD Medical Consulting AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ted Hans Erik Karlsson | Audit | 0 companies |
| Björn Lennart Dahlöf | Board of Directors | 0 companies |
| Björn Andreas Dahlöf | Deputy Board Member | 0 companies |